Sun; Yaping
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sun; Yaping.The latest application filed is for "bicyclic heterocycles as fgfr inhibitors".
Company Profile
10.17.30
- Sun; Yaping - Ann Arbor MI
- Sun; Yaping - Lansdale PA
- Sun; Yaping - Hockessin DE
- Sun; Yaping - Hangzhou CN
- Sun; Yaping - Lexington MA
- Sun, Yaping - Norwood MA
- Sun, Yaping - Arlington MA
Patent Activity
| Patent | Date |
|---|---|
| Materials and methods for modifying the activity of T cells Grant 11,390,848 - Blazar , et al. July 19, 2 | 2022-07-19 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20210395246 - Sun; Yaping ; et al. | 2021-12-23 |
| Bicyclic heterocycles as FGFR inhibitors Grant 10,947,230 - Sun , et al. March 16, 2 | 2021-03-16 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20200377504 - Wu; Liangxing ; et al. | 2020-12-03 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20200095244 - Sun; Yaping ; et al. | 2020-03-26 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 10,556,908 - Wu , et al. Feb | 2020-02-11 |
| Materials And Methods For Modifying The Activity Of T Cells App 20190203173 - Blazar; Bruce R. ; et al. | 2019-07-04 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20190152976 - Wu; Liangxing ; et al. | 2019-05-23 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20190127376 - Wu; Liangxing ; et al. | 2019-05-02 |
| Imidazopyrazines As Lsd1 Inhibitors App 20190106426 - Wu; Liangxing ; et al. | 2019-04-11 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20190062327 - Sun; Yaping ; et al. | 2019-02-28 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 10,112,950 - Wu , et al. October 30, 2 | 2018-10-30 |
| Bicyclic heterocycles as FGFR inhibitors Grant 10,040,790 - Sun , et al. August 7, 2 | 2018-08-07 |
| Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors Grant 9,890,162 - Sun , et al. February 13, 2 | 2018-02-13 |
| Imidazopyrazines As Lsd1 Inhibitors App 20170369497 - Wu; Liangxing ; et al. | 2017-12-28 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20170362245 - Wu; Liangxing ; et al. | 2017-12-21 |
| Heterocyclic compounds and uses thereof Grant 9,840,503 - Sun , et al. December 12, 2 | 2017-12-12 |
| Bicyclic Aromatic Carboxamide Compounds Useful As Pim Kinase Inhibitors App 20170253587 - Sun; Yaping ; et al. | 2017-09-07 |
| Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Grant 9,695,180 - Wu , et al. July 4, 2 | 2017-07-04 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20170166564 - Sun; Yaping ; et al. | 2017-06-15 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20170137424 - Wu; Liangxing ; et al. | 2017-05-18 |
| Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors Grant 9,580,418 - Sun , et al. February 28, 2 | 2017-02-28 |
| Bicyclic heterocycles as FGFR inhibitors Grant 9,533,984 - Sun , et al. January 3, 2 | 2017-01-03 |
| Data recovery method, data recovery device and distributed storage system Grant 9,529,675 - Ma , et al. December 27, 2 | 2016-12-27 |
| Heterocyclic Compounds And Uses Thereof App 20160333008 - Sun; Yaping ; et al. | 2016-11-17 |
| Method and apparatus for determining redundant array of independent disks Grant 9,389,790 - Xu , et al. July 12, 2 | 2016-07-12 |
| Capacity expansion method and device Grant 9,354,826 - Xu , et al. May 31, 2 | 2016-05-31 |
| Bicyclic Aromatic Carboxamide Compounds Useful As Pim Kinase Inhibitors App 20160009714 - Sun; Yaping ; et al. | 2016-01-14 |
| Imidazopyrazines As Lsd1 Inhibitors App 20160009720 - Wu; Liangxing ; et al. | 2016-01-14 |
| Triazolopyridines And Triazolopyrazines As Lsd1 Inhibitors App 20160009721 - Wu; Liangxing ; et al. | 2016-01-14 |
| Method And Apparatus For Determining Redundant Array Of Independent Disks App 20150178004 - XU; Yan ; et al. | 2015-06-25 |
| Data Recovery Method, Data Recovery Device And Distributed Storage System App 20150033070 - Ma; Xiaohui ; et al. | 2015-01-29 |
| Methods Of Modulating Immunological Responses By Administering Truncated Baff Receptors App 20150023961 - Ambrose; Christine ; et al. | 2015-01-22 |
| Capacity Expansion Method And Device App 20140351512 - Xu; Yan ; et al. | 2014-11-27 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20140315902 - Sun; Yaping ; et al. | 2014-10-23 |
| Method of treating B cell cancers by administering truncated BAFF receptors Grant 8,821,883 - Ambrose , et al. September 2, 2 | 2014-09-02 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20130338134 - Wu; Liangxing ; et al. | 2013-12-19 |
| Method of Treating Immunological Disorders by Administering Truncated BAFF Receptors App 20130177558 - Ambrose; Christine ; et al. | 2013-07-11 |
| Method of treating immunological disorders by administering truncated BAFF receptors Grant 8,303,958 - Ambrose , et al. November 6, 2 | 2012-11-06 |
| Truncated Baff Receptors App 20110311530 - Ambrose; Christine ; et al. | 2011-12-22 |
| Truncated BAFF receptors Grant 8,022,182 - Ambrose , et al. September 20, 2 | 2011-09-20 |
| Truncated BAFF Receptors App 20100184951 - Ambrose; Christine ; et al. | 2010-07-22 |
| Truncated baff receptors Grant 7,700,317 - Ambrose , et al. April 20, 2 | 2010-04-20 |
| Truncated baff receptors App 20060234917 - Ambrose; Christine ; et al. | 2006-10-19 |
| Expression and export of interferon-alpha proteins as Fc fusion proteins App 20050042729 - Lo, Kin-Ming ; et al. | 2005-02-24 |
| Expression and export of interferon-alpha proteins as Fc fusion proteins App 20020081664 - Lo, Kin-Ming ; et al. | 2002-06-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 